Related Experiment Video
Updated: Jul 20, 2026
08:56
Estrogen-Like Effect of Bazi Bushen Capsule in Ovariectomized Rats
Published on: April 7, 2023
Ginkgo biloba for antidepressant-induced sexual dysfunction
Journal of Sex & Marital Therapy
|June 5, 1998
Summary
Ginkgo biloba effectively treated antidepressant-induced sexual dysfunction in 84% of participants. This herbal supplement positively impacted all sexual response phases, with women showing greater responsiveness than men.
Area of Science:
- Pharmacology
- Herbal Medicine
- Sexual Health
Background:
- Antidepressant medications, particularly selective serotonin reuptake inhibitors (SSRIs), frequently cause sexual dysfunction.
- Ginkgo biloba, known for cognitive enhancement, was observed to improve erectile function in a geriatric patient.
- Sexual dysfunction is a common and distressing side effect of various antidepressant classes.
Purpose of the Study:
- To evaluate the efficacy of Ginkgo biloba in treating antidepressant-induced sexual dysfunction.
- To assess the impact of Ginkgo biloba across all phases of the sexual response cycle.
- To compare the effectiveness of Ginkgo biloba between genders for sexual dysfunction.
Main Methods:
- An open-label trial involving 63 participants with antidepressant-induced sexual dysfunction.
- Participants received varying dosages of Ginkgo biloba extract (average 209mg/d).
- Data collected on sexual function across desire, excitement, orgasm, and resolution phases.
Main Results:
- Ginkgo biloba demonstrated an 84% overall effectiveness rate in treating sexual dysfunction.
- Women (91% success rate) responded better than men (76% success rate).
- Positive effects were observed across all four phases of the sexual response cycle.
Conclusions:
- Ginkgo biloba is a promising treatment for antidepressant-induced sexual dysfunction.
- The herb positively influences multiple aspects of sexual function.
- Further research into its mechanisms, including effects on neurotransmitters and vasodilation, is warranted.
More Related Videos
04:22Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
Published on: May 30, 2025
08:15Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
Related Concept Videos
01:21G-protein Coupled Receptors
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
01:25Antidepressant Drugs: Overview
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
01:23Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
01:28Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
01:17Male Sexual Response: Erection & Ejaculation
Sexual stimulation can take various forms, such as physical touch and visual or auditory cues. When this happens, the parasympathetic reflex in the sacral portion of the spinal cord is activated. This reflex stimulates the release of nitric oxide (NO), which then dilates the arterioles in the penis, increasing blood flow to the erectile tissues - the corpora cavernosa and corpus spongiosum.
The blood filling the erectile tissues compresses the veins, which helps to prevent blood from leaving...
The blood filling the erectile tissues compresses the veins, which helps to prevent blood from leaving...
01:08Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...